Gilead Sciences, Inc.
GILD
$114.43
-$2.78-2.37%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 0.32% | 8.51% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.32% | 8.51% | |||
| Cost of Revenue | 0.44% | 1.94% | |||
| Gross Profit | 0.28% | 10.39% | |||
| SG&A Expenses | 31.99% | 2.99% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 15.69% | 2.77% | |||
| Operating Income | -20.94% | 17.61% | |||
| Income Before Tax | 126.78% | -53.41% | |||
| Income Tax Expenses | 229.63% | -167.81% | |||
| Earnings from Continuing Operations | 42.30% | -22.37% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 42.30% | -22.37% | |||
| EBIT | -20.94% | 17.61% | |||
| EBITDA | -17.12% | 13.88% | |||
| EPS Basic | 42.19% | -22.37% | |||
| Normalized Basic EPS | -21.23% | 19.38% | |||
| EPS Diluted | 40.89% | -22.48% | |||
| Normalized Diluted EPS | -21.49% | 19.09% | |||
| Average Basic Shares Outstanding | 0.08% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.40% | 0.24% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.30% | 0.30% | |||
